Vous avez cherché: mskcc (Anglais - Roumain)

mskcc prognostic score (blinded independent central review)
scor de prognostic mskcc (analiză centrală, independentă, oarbă)

age, mskcc prognostic group, ecog ps and prior therapy did not affect the treatment effect size.
vârsta, grupa de risc prognostic conform mskcc, indicele de performanţă ecog şi terapia anterioară nu au afectat gradul de eficacitate a tratamentului.

approximately half of the patients had an ecog performance status of 0, and half of the patients were in the low risk mskcc prognostic group.
aproximativ jumătate dintre pacienţi au avut un indice de performanţă ecog egal cu 0, iar altă jumătate s- au situat în grupa de risc prognostic scăzut, conform modelului mskcc.

only patients with clear cell renal carcinoma and low and intermediate risk mskcc (memorial sloan kettering cancer center) were included.
au fost incluşi numai pacienţii cu carcinom renal cu celule clare şi cu risc prognostic scăzut şi intermediar, conform mskcc (memorial sloan kettering cancer center).

high risk patients, according to mskcc (memorial sloan kettering cancer center) prognostic group, were not included in the phase iii clinical study in renal cell carcinoma (see study 1 in section 5.1); and benefit-risk in these patients has not been evaluated.
pacienţii cu risc înalt conform modelului de risc prognostic mskcc (memorial sloan kettering cancer center) nu au fost incluşi în studiul clinic de fază iii, iar raportul beneficiu- risc nu a fost evaluat pentru aceşti pacienţi.